Firebrick Pharma Limited ( ($AU:FRE) ) has issued an announcement. Firebrick Pharma Limited has announced the acceptance of its COVID-19 patent by ...

Scientists in Birmingham say they are close to launching a new hay fever spray treatment that grew out of work on Covid.

The MHRA has approved a nasal spray adrenaline formulation that offers the first needle-free alternative for the emergency treatment of anaphylaxis.

Life-saving nasal spray treatment for anaphylaxis now available in UK The first needle-free emergency treatment for anaphylaxis has been approved for use ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

The first needle-free emergency treatment for anaphylaxis - in the form of a nasal spray - will now be available in the UK.

A new nasal spray was developed at a Harvard University-affiliated hospital that appears to slow down the progression of Alzheimer's disease symptoms. "It can be given with other treatments," Dr ...

Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial ...

The Wiest family tells Action News Jax they first got Neffy, a nasal spray treatment for severe allergies, after it was ...

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights ...